Posts in category Insights


Analyst Sees Over 160% Upside for IntelliPharmaCeutics Intl Inc (USA) Stock

It can be tricky putting a price tag on a biotech company, especially one that …

Could Hospitals Making Generic Assets Impact Teva Pharmaceutical Industries Ltd (ADR) and Endo International plc? Analysts Answer

A NYT article has Wall Street abuzz today with whispers of non-profit hospital groups creating a new generics maker or partnering with third party manufacturers.

Don’t Get Jittery on Valeant Pharmaceuticals Intl Inc Just Because of Prospective Cosmo Rivalry, Argues Louise Chen

Cantor’s Louise Chen dismisses Valeant share weakness today, making a bullish case that the majority of Xifaxan’s sales stem from IBS-D; not Traveler’s Diarrhea.

Advanced Micro Devices, Inc.’s and NVIDIA Corporation’s Crypto-Mania May Be Nearing Its End: Christopher Rolland

Crypto-related GPU sales appear to be more massive than AMD and NVDA had expected in 4Q17; here’s why Susquehanna’s Christopher Rolland says this could be an issue.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Just Lost a Bull

Though BTIG’s Tim Chiang sees a recovery in the works for TEVA, he sees shares as “fairly valued” at currently levels.

International Business Machines Corp. (IBM): Buy the Dip or Pump the Brakes?

Oppenheimer’s Ittai Kidron asks where can IBM “go from here” following two consecutive years of gross margin downturns in every segment?

Here’s Why International Business Machines Corp. Shares Are Falling Following 4Q Earnings Beat

After the bell, International Business Machines Corp. (NYSE:IBM) reported fourth-quarter earnings, showing positive revenue growth …

Apple Inc. Gets Price Target Hike Ahead of Earnings; Here’s Why You Shouldn’t Be Excited

Tech giant Apple Inc. (NASDAQ:AAPL) received a price-target hike from a Wall Street firm on …

All Eyes on International Business Machines (IBM) 4Q Earnings Tonight

Cantor’s Joseph Foresi highlights some positives in IBM’s favor approaching tonight’s quarterly results, but still sees more downside risk than upside gain to shares.

Analyst Sees Optimism on Kinder Morgan Inc (KMI) into 2018 on Back of Improving G&P Segment

RBC Capital’s Elvira Scotto projects 15% in return potential for KMI stock following the 4Q earnings showcase.

Show More